4
Changes in Ownership
Edgewise Therapeutics, Inc. Filed Acc 0001562180-22-005251
General Counsel sold 67,927 shares at an average $6.83 ($463,935)
- General Counsel acquired 67,927 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/primarydocument.xml…